DHTRF (DRI Healthcare Trust) LT-Debt-to-Total-Asset: 0.50 (As of Mar. 2026)

What is DRI Healthcare Trust LT-Debt-to-Total-Asset?

DRI Healthcare Trust DHTRF 33 LT-Debt-to-Total-Asset is 0.50 as of Mar. 2026. GuruFocus rates DHTRF with a GF Score™ of 33/100 and a GF Value™ of $13.28 (Fairly Valued). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. DRI Healthcare Trust's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.50.

DRI Healthcare Trust's long-term debt to total assets ratio increased from Mar. 2025 (0.32) to Mar. 2026 (0.50). It may suggest that DRI Healthcare Trust is progressively becoming more dependent on debt to grow their business.

DRI Healthcare Trust (OTCPK:DHTRF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

DRI Healthcare Trust LT-Debt-to-Total-Asset Related Terms

DRI Healthcare Trust LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for DRI Healthcare Trust's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DRI Healthcare Trust LT-Debt-to-Total-Asset Chart

DRI Healthcare Trust Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

0.10

0.39

0.18

0.33

0.40

DRI Healthcare Trust Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.32	0.35	0.38	0.40	0.50

33GF Score

DRI Healthcare Trust DHTRF

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

DRI Healthcare Trust LT-Debt-to-Total-Asset Calculation

DRI Healthcare Trust's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	376.064	/	942.819
	=	0.40

DRI Healthcare Trust's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	456.056	/	916.384
	=	0.50

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.50 mean?

DRI Healthcare Trust (DHTRF) has a LT-Debt-to-Total-Asset of 0.50 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on DRI Healthcare Trust and its competitors.

Is DRI Healthcare Trust's LT-Debt-to-Total-Asset too high?

DRI Healthcare Trust's current LT-Debt-to-Total-Asset is 0.50. Overall, DRI Healthcare Trust has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does DRI Healthcare Trust's LT-Debt-to-Total-Asset compare to ZTS and UTHR?

DRI Healthcare Trust's LT-Debt-to-Total-Asset of 0.50 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?

A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on DRI Healthcare Trust and its competitors. DRI Healthcare Trust's current LT-Debt-to-Total-Asset is 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is DRI Healthcare Trust stock overvalued right now?

Based on GuruFocus' analysis, DRI Healthcare Trust (DHTRF) is currently considered Fairly Valued. The stock's GF Value™ is $13.28, compared to a current price of $12.70 — trading 4.4% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.50. DRI Healthcare Trust's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For DRI Healthcare Trust (DHTRF), the current LT-Debt-to-Total-Asset is 0.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DRI Healthcare Trust (DHTRF) Overvalued in 2026?

Based on GuruFocus' analysis, DRI Healthcare Trust stock appears to be undervalued. The current stock price of $12.70 is trading 4.4% below its estimated GF Value™ of $13.28. GuruFocus considers DRI Healthcare Trust to be Fairly Valued.

Key valuation signals for DHTRF:

LT-Debt-to-Total-Asset: 0.50
GF Value™: $13.28 vs. price of $12.70 (4.4% below fair value)
GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the DHTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DRI Healthcare Trust Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSX:GUD XCNQ:VREO NEOE:VRNO TSX:WEED NEOE:GLAS.A.U XCNQ:CL TSX:CPH TSX:CRON TSX:TSND TSX:XLY XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges DHT.UN:Canada DHT.U:Canada

Address 100 King Street West, 1 First Canadian Place, Suite 6200, Toronto, ON, CAN, M5X 1B8

Website https://drihealthcare.com

DRI Healthcare Trust is an open-ended trust that purchases royalty entitlements on products that address unmet medical needs, providing its unitholders with top-line exposure to a portfolio of therapeutics. Its portfolio comprises several royalty streams on products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically, it generates maximum royalty income from the sale of products underlying its royalty agreements in the United States, followed by other markets such as Japan, the European Union, and the rest of the world.

33GF Score

Get the complete analysis for DHTRF

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.70

Price

$13.28

GF Value

View DHTRF Analysis

See LT-Debt-to-Total-Asset data for all stocks →